IRIS
BUTTARI, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 325
NA - Nord America 257
AS - Asia 256
SA - Sud America 1
Totale 839
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 242
DE - Germania 179
SG - Singapore 131
HK - Hong Kong 117
IT - Italia 88
EE - Estonia 15
CA - Canada 14
FI - Finlandia 11
GB - Regno Unito 10
BE - Belgio 7
RU - Federazione Russa 6
NL - Olanda 5
BD - Bangladesh 3
IL - Israele 3
LT - Lituania 3
PK - Pakistan 2
BR - Brasile 1
CH - Svizzera 1
MX - Messico 1
Totale 839
Salva come PNG Salva come JPEG
Città #
Hong Kong 117
Falkenstein 102
Frankfurt am Main 71
West Jordan 62
Rome 55
Chicago 51
Boardman 35
Singapore 31
Helsinki 11
Toronto 8
Brussels 7
Moscow 6
Ottawa 6
Buffalo 5
London 5
Naples 5
Bologna 4
Sant'Elpidio a Mare 4
Ashburn 3
Charlotte 3
Ettlingen 3
Galbiate 3
Santa Clara 3
Amsterdam 2
Elk Grove Village 2
Zona Industriale 2
Arosio 1
Council Bluffs 1
Grellingen 1
Kiryat Ono 1
Los Angeles 1
Mexico City 1
São Paulo 1
Totale 613
Salva come PNG Salva come JPEG
Nome #
Cerebrospinal fluid inflammatory biomarkers predicting interferon-beta response in MS patients 27
Modeling Resilience to Damage in Multiple Sclerosis: Plasticity Meets Connectivity 25
Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis 25
Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis 24
Genetic regulation of IL-8 influences disease presentation of multiple sclerosis 24
BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis 23
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis 23
Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis 23
IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis 21
Interaction between miR-142-3p and BDNF Val/Met Polymorphism Regulates Multiple Sclerosis Severity. 21
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis. 21
Exploiting the multifaceted effects of cannabinoids on mood to boost their therapeutic use against anxiety and depression 21
Obesity worsens central inflammation and disability in multiple sclerosis 21
Exercise protects from hippocampal inflammation and neurodegeneration in experimental autoimmune encephalomyelitis 21
Cerebrospinal fluid levels of L-glutamate signal central inflammatory neurodegeneration in multiple sclerosis 20
Osteopontin Is Associated with Multiple Sclerosis Relapses 20
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis 20
Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis 20
Inflammation and Corticospinal Functioning in Multiple Sclerosis: A TMS Perspective 20
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis 20
Interleukin-1β Alters Hebbian Synaptic Plasticity in Multiple Sclerosis 20
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis 19
Transient receptor potential vanilloid 1 modulates central inflammation in multiple sclerosis 19
A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine Treatment 19
Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients 19
Cerebrospinal fluid, brain, and spinal cord levels of L-aspartate signal excitatory neurotransmission abnormalities in multiple sclerosis patients and experimental autoimmune encephalomyelitis mouse model 19
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 18
Synaptic plasticity shapes brain connectivity: Implications for network topology 18
Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity 18
Practice-dependent motor cortex plasticity is reduced in non-disabled multiple sclerosis patients 16
Age at Disease Onset Associates With Oxidative Stress, Neuroinflammation, and Impaired Synaptic Plasticity in Relapsing-Remitting Multiple Sclerosis 16
Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis 16
Preventive exercise and physical rehabilitation promote long-term potentiation-like plasticity expression in patients with multiple sclerosis 15
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis 15
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis 15
Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis 15
Remodeling functional connectivity in multiple sclerosis: A challenging therapeutic approach 15
Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression 14
An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple Sclerosis 14
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis 14
Peripheral T cells from multiple sclerosis patients trigger synaptotoxic alterations in central neurons 14
Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation. 14
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis 14
Immunomodulatory Effects of Exercise in Experimental Multiple Sclerosis 14
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple Sclerosis 14
miR-142-3p Is a Key Regulator of IL-1??-Dependent Synaptopathy in Neuroinflammation 13
Re-Examining the Role of TNF in MS Pathogenesis and Therapy 13
Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions 12
Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation 12
'Prototypical' proinflammatory cytokine (IL-1) in multiple sclerosis: role in pathogenesis and therapeutic targeting 12
Voluntary running wheel attenuates motor deterioration and brain damage in cuprizone-induced demyelination 11
Totale 917
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.068
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.068
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024198 0 0 0 0 0 0 45 0 0 125 15 13
2024/2025719 35 45 7 49 81 57 187 186 52 20 0 0
Totale 917